dacarbazine has been researched along with Day Blindness in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhaumik, G; Chatterjee, K | 1 |
Hyodo, A; Nagaishi, M; Sugiura, Y; Suzuki, K; Takano, I; Tanaka, Y; Yokoo, H | 1 |
Dambatta, S; Grundy, PL; Vajramani, GV; Walker, M | 1 |
Barada, WM; Bazarbachi, A; Beydoun, A; Hourani, R; Masroujeh, R; Otrock, ZK | 1 |
Dehesdin, D; Fréger, P; Laquerrière, A; Proust, F; Velche-Haag, B | 1 |
Kretschmar, CS; Linggood, RM | 1 |
Lambrecht, ER; van der Eerden, AH; van der Loos, TL | 1 |
2 review(s) available for dacarbazine and Day Blindness
Article | Year |
---|---|
[Ewing's sarcoma of the ethmoid bone. Case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dacarbazine; Dactinomycin; Diagnostic Errors; Doxorubicin; Esthesioneuroblastoma, Olfactory; Ethmoid Bone; Facial Pain; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Skull Neoplasms; Vincristine; Vision Disorders | 2002 |
Chemotherapeutic treatment of extensive optic pathway tumors in infants.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Astrocytoma; Cerebrospinal Fluid Shunts; Cisplatin; Cranial Nerve Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Dwarfism, Pituitary; Female; Humans; Hydrocephalus; Infant; Male; Mechlorethamine; Neoplasm Invasiveness; Optic Chiasm; Optic Nerve Diseases; Peritoneal Neoplasms; Vincristine; Vision Disorders | 1991 |
5 other study(ies) available for dacarbazine and Day Blindness
Article | Year |
---|---|
Spindle cell sarcoma of the maxillary antrum.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Dose Fractionation, Radiation; Doxorubicin; Epistaxis; Humans; Male; Maxillary Sinus Neoplasms; Sarcoma; Vincristine; Vision Disorders | 2012 |
Clinicopathological and molecular features of malignant optic pathway glioma in an adult.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Glioma; Humans; Isocitrate Dehydrogenase; Middle Aged; Optic Nerve Glioma; Radiosurgery; Temozolomide; Vision Disorders; Visual Fields | 2015 |
Multiple gangliogliomas of the optic pathway.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Ganglioglioma; Humans; Magnetic Resonance Imaging; Male; Optic Nerve Neoplasms; Temozolomide; Treatment Outcome; Vision Disorders | 2006 |
Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Topics: Adult; Alkalosis, Respiratory; Amnesia, Retrograde; Amnesia, Transient Global; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Confusion; Cryoprotective Agents; Cytarabine; Dacarbazine; Dexamethasone; Dimethyl Sulfoxide; Doxorubicin; Etoposide; Hippocampus; Hodgkin Disease; Humans; Hyperventilation; Ifosfamide; Magnetic Resonance Imaging; Male; Melphalan; Paresthesia; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Vinblastine; Vision Disorders | 2008 |
Retrobulbar neuritis as the first sign of the glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Dacarbazine; Diagnosis, Differential; Eye; Glucagonoma; Humans; Male; Middle Aged; Neuritis; Pancreatic Neoplasms; Scotoma; Vision Disorders | 1987 |